Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Net Margin (2017 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Net Margin for 16 consecutive years, with 0.39% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 478.0% to 0.39% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 31.58% through Dec 2025, down 3115.0% year-over-year, with the annual reading at 31.58% for FY2025, 3115.0% down from the prior year.
  • Net Margin hit 0.39% in Q4 2025 for Integra Lifesciences Holdings, up from 1.34% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 13.3% in Q4 2022 to a low of 116.47% in Q2 2025.
  • Historically, Net Margin has averaged 0.97% across 5 years, with a median of 5.05% in 2023.
  • Biggest five-year swings in Net Margin: surged 1002bps in 2021 and later crashed -11351bps in 2025.
  • Year by year, Net Margin stood at 11.19% in 2021, then increased by 19bps to 13.3% in 2022, then tumbled by -62bps to 5.0% in 2023, then fell by -12bps to 4.39% in 2024, then crashed by -109bps to 0.39% in 2025.
  • Business Quant data shows Net Margin for IART at 0.39% in Q4 2025, 1.34% in Q3 2025, and 116.47% in Q2 2025.